<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-04-28</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38678389/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">scBOL: a universal cell type identification framework for single-cell and spatial transcriptomics data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38678389-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MOTIVATION: Over the past decade, single-cell transcriptomic technologies have experienced remarkable advancements, enabling the simultaneous profiling of gene expressions across thousands of individual cells. Cell type identification plays an essential role in exploring tissue heterogeneity and characterizing cell state differences. With more and more well-annotated reference data becoming available, massive automatic identification methods have sprung up to simplify the annotation process &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObLEhz8D3">SF downtownçš„è‘—åç‰›æ’é¤å…Mastroâ€™sã€‚æƒ³ä¸åˆ°SFè¿˜æœ‰å¯¹ç€è£…æœ‰è¦æ±‚çš„é¤å…ã€‚è¿™é‡Œçš„Bone in Kansas stripååˆ†ç¾å‘³ã€‚Fire Mongoä¹Ÿæ˜¯ä¸€ç»ã€‚ ç¾å›½Â·è”åˆå¹¿åœº Union Squa...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oblehz8d3/">
    
    
    
    
    
      
    
    SF downtownçš„è‘—åç‰›æ’é¤å…Mastroâ€™sã€‚æƒ³ä¸åˆ°SFè¿˜æœ‰å¯¹ç€è£…æœ‰è¦æ±‚çš„é¤å…ã€‚è¿™é‡Œçš„Bone in Kansas stripååˆ†ç¾å‘³ã€‚Fire Mongoä¹Ÿæ˜¯ä¸€ç»ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å›½Â·è”åˆå¹¿åœº Union Square Park<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/">https://tvax2.sinaimg.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObNQVjApF">2024 White House Correspondents Dinner - Colin Jostå¤ªæŸäº†ï¼Œä¿æŒäº†Weekend Updateä¸€è´¯çš„é˜´é˜³æ€ªæ°”ï¼Œè¿˜ä¿æŒäº†ä½œä¸ºç™½äººç”·æ€§çš„è‡ªé»‘ã€‚RFK Jr - Like his vaccinati...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obnqvjapf/">
    
    
    
    
    
      
    
    2024 White House Correspondents Dinner - Colin Jostå¤ªæŸäº†ï¼Œä¿æŒäº†Weekend Updateä¸€è´¯çš„é˜´é˜³æ€ªæ°”ï¼Œè¿˜ä¿æŒäº†ä½œä¸ºç™½äººç”·æ€§çš„è‡ªé»‘ã€‚RFK Jr - Like his vaccination card said, he doesnâ€™t have a shot.  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObMsfeZ5b">å¾ˆå¤šäººæåˆ°æŸ³å·ï¼Œç¬¬ä¸€æ—¶é—´ä¼šæƒ³åˆ°èºè›³ç²‰ï¼Œå…¶å®æŸ³å·çš„å·¥ä¸šæ–‡åŒ–ä¹Ÿå€¼å¾—æ¢è®¿ä¸€ä¸‹ã€‚ä¸€å¤§æ—©ï¼Œæˆ‘è·‘åˆ°æŸ³æ±Ÿæ±Ÿç•”çš„å·¥ä¸šåšç‰©é¦†ï¼Œè¿™é‡Œçš„é™ˆåˆ—ä¸»é¢˜æ˜¯æŸ³å·ä»æ¸…æœ«åˆ°å½“ä»£çš„å·¥ä¸šå‘å±•...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obmsfez5b/">
    
    
    
    
    
      
    
    å¾ˆå¤šäººæåˆ°æŸ³å·ï¼Œç¬¬ä¸€æ—¶é—´ä¼šæƒ³åˆ°èºè›³ç²‰ï¼Œå…¶å®æŸ³å·çš„å·¥ä¸šæ–‡åŒ–ä¹Ÿå€¼å¾—æ¢è®¿ä¸€ä¸‹ã€‚ä¸€å¤§æ—©ï¼Œæˆ‘è·‘åˆ°æŸ³æ±Ÿæ±Ÿç•”çš„å·¥ä¸šåšç‰©é¦†ï¼Œè¿™é‡Œçš„é™ˆåˆ—ä¸»é¢˜æ˜¯æŸ³å·ä»æ¸…æœ«åˆ°å½“ä»£çš„å·¥ä¸šå‘å±•è¿›ç¨‹ï¼Œä»æ°‘é—´æœ¨è´¨æ¦¨ç³–æœºåˆ°ä¸°æ”¶ç‰Œæ‹–æ‹‰æœºï¼Œä»æœ¨ç‚­æ±½è½¦åˆ°ç”¨åºšå­èµ”æ¬¾é€ çš„æœºåºŠï¼Œä¸€åº”ä¿±å…¨ï¼Œå¾ˆå¤šéƒ½æ˜¯æœ‰ç€ç™¾å¹´å†å²çš„è€æœºå™¨è€ç‰©ä»¶å„¿ã€‚å¸ƒå±•ååˆ†ç”¨å¿ƒï¼Œæ•´ä¸ªè£…ä¿®é£æ ¼é¢‡æœ‰è’¸æœ‹ä¹‹æ„Ÿã€‚å¾œå¾‰å…¶é—´ï¼Œèƒ½æ„Ÿå—åˆ°ä¸€ç§ç£…ç¤´çš„æ°”åŠ¿ï¼Œä»¿ä½›æœ‰ä¸€å°å·¨å¤§çš„æœºå™¨åœ¨ç‰µå¼•ç€æ—¶ä»£ï¼Œéš†éš†å‰è¡Œã€‚å€¼å¾—å¸¦å­©å­æ¥çœ‹çœ‹ï¼Œè®©ä»–ä»¬äº²èº«ä½“ä¼šåˆ°ï¼Œå·¥ä¸šå¦‚ä½•æ·±åˆ»åœ°æ”¹å˜äººç±»æ–‡æ˜ï¼Œæ”¹å˜è¿™ä¸ªå›½å®¶çš„å‘½è¿ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->é¡ºä¾¿ï¼Œæœ€åä¸€å¼ å›¾ï¼Œæˆ‘å·®ç‚¹çœ‹å“­äº†ã€‚é‚£æ˜¯ä¸€å°æŸ³å·äº§çš„é±¼å³°ç‰Œåäº”å¤©é‡‘å£°æœ¨åº§é’Ÿã€‚æˆ‘çˆ·çˆ·å¥¶å¥¶å®¶ï¼Œå°±æœ‰è¿™ä¹ˆä¸€å°åº§é’Ÿï¼Œä¸€æ¨¡ä¸€æ ·ã€‚æˆ‘å°æ—¶å€™æœ€å–œæ¬¢çš„äº‹ï¼Œå°±æ˜¯æ‰“å¼€é’Ÿåº§åèƒŒï¼Œä»é‡Œé¢æå‡ºé’¥åŒ™ï¼Œæ’å…¥æ­£é¢çš„å‘æ¡å­”ï¼Œå’¯å±å’¯å±åœ°ä¸Šå‘æ¡ã€‚è¿™æ˜¯æˆ‘ç«¥å¹´æœ€ç¾å¥½çš„å›å¿†ä¹‹ä¸€ï¼Œæ²¡æƒ³åˆ°åœ¨è¿™é‡Œé‡é€¢äº†ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%96%E7%95%8C%E8%AF%BB%E4%B9%A6%E6%97%A5%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%96%E7%95%8C%E8%AF%BB%E4%B9%A6%E6%97%A5%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObMz8hrTz">åˆšåˆšåœ¨æŸ³å·å·¥ä¸šåšç‰©é¦†ï¼Œè¿˜çœ‹åˆ°ä¸€å¼ ç›¸å…³çš„ç…§ç‰‡ã€‚è‡ªä»å†™å®Œå¤§åŒ»ä¹‹åï¼Œå¯¹è¿™ç±»é¢˜ææ ¼å¤–æ•é”ã€‚ æŸ¥çœ‹å›¾ç‰‡ - è½¬å‘ @ä¸‡_å²_çº¢_é¢œ:&amp;ensp;è¯»ä¹¦#è¯»ä¹¦##çƒ­é—¨å°è¯´æ¨è##å¤§åŒ»# ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obmz8hrtz/">
    
    
    
    
    
      
    
    åˆšåˆšåœ¨æŸ³å·å·¥ä¸šåšç‰©é¦†ï¼Œè¿˜çœ‹åˆ°ä¸€å¼ ç›¸å…³çš„ç…§ç‰‡ã€‚è‡ªä»å†™å®Œå¤§åŒ»ä¹‹åï¼Œå¯¹è¿™ç±»é¢˜ææ ¼å¤–æ•é”ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¥çœ‹å›¾ç‰‡<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a href=&ldquo;<a href="https://weibo.com/1722413652%22">https://weibo.com/1722413652&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObNmIftHr">å—¦èºèºï½å—¦èºèºï½ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obnmifthr/">
    
    
    
    
    
      
    
    å—¦èºèºï½å—¦èºèºï½ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRBq2oJS">æ–°é—»è¯´äº†ï¼Œæ²¡ç³»å®‰å…¨å¸¦çš„å®‰å…¨éƒ¨é•¿ã€‚//@ä»å¿ƒæ°´å·¥:è¿™éƒ½èƒ½è‚‹éª¨éª¨æŠ˜ ä¸«ç»å¯¹æ²¡æ “å®‰å…¨å¸¦//@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:é¡¶ç€å‡ æ ¹è‚‹éª¨éª¨æŠ˜å‡ºé™¢äº†ï¼Œç°åœ¨è¿™èŠ‚éª¨çœ¼ä¸æ•¢èººã€‚//@åšæ‰‹çƒ«ä¼¤:...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrbq2ojs/">
    
    
    
    
    
      
    
    æ–°é—»è¯´äº†ï¼Œæ²¡ç³»å®‰å…¨å¸¦çš„å®‰å…¨éƒ¨é•¿ã€‚//<!-- raw HTML omitted -->@ä»å¿ƒæ°´å·¥<!-- raw HTML omitted -->:è¿™éƒ½èƒ½è‚‹éª¨éª¨æŠ˜ ä¸«ç»å¯¹æ²¡æ “å®‰å…¨å¸¦//<!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:é¡¶ç€å‡ æ ¹è‚‹éª¨éª¨æŠ˜å‡ºé™¢äº†ï¼Œç°åœ¨è¿™èŠ‚éª¨çœ¼ä¸æ•¢èººã€‚//<!-- raw HTML omitted -->@åšæ‰‹çƒ«ä¼¤<!-- raw HTML omitted -->:æœ¬æ ¼ç»´å°”ä¸æ˜¯è¿˜åœ¨åŒ»é™¢ï¼Ÿå†…å¡”æŠ“ä½æ—¶é—´å·®èµ¶ç´§æŠŠåè®®ç­¾äº†<!-- raw HTML omitted -->&lt;img alt=&quot;[æ€’]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_nu-0ddf642bed.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_nu-0ddf642bed.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRG81oBH">ğŸ”»å›¾1æ˜¯å°ç¬¬å®‰çº³å¤§å­¦å†…çš„ç‹™å‡»æ‰‹ã€‚ğŸ”»è¿™æªåŒ…æˆ‘è®¤è¯†ï¼Œæ˜¯eberlestockçš„ï¼Œç¾å›½å†›è­¦ç‹™å‡»æ‰‹å’ŒçŒæ‰‹éƒ½çˆ±ç”¨ï¼Œä¾¿å®œé‡åˆè¶³ã€‚ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrg81obh/">
    
    
    
    
    
      
    
    ğŸ”»å›¾1æ˜¯å°ç¬¬å®‰çº³å¤§å­¦å†…çš„ç‹™å‡»æ‰‹ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™æªåŒ…æˆ‘è®¤è¯†ï¼Œæ˜¯eberlestockçš„ï¼Œç¾å›½å†›è­¦ç‹™å‡»æ‰‹å’ŒçŒæ‰‹éƒ½çˆ±ç”¨ï¼Œä¾¿å®œé‡åˆè¶³ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRHY2LO9">ä½ åˆä¸æ‰“çŒä½ è¦é“¾æ¥å¹²ä»€ä¹ˆï¼Ÿ//@ä¸è™šæ­¤è¡Œå¬å¸ƒå¿:æœ‰é“¾æ¥å—[äºŒå“ˆ] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å›¾1æ˜¯å°ç¬¬å®‰çº³å¤§å­¦å†…çš„ç‹™å‡»æ‰‹ã€‚ğŸ”»è¿™æªåŒ…æˆ‘è®¤è¯†ï¼Œæ˜¯eberlesto...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrhy2lo9/">
    
    
    
    
    
      
    
    ä½ åˆä¸æ‰“çŒä½ è¦é“¾æ¥å¹²ä»€ä¹ˆï¼Ÿ//<!-- raw HTML omitted -->@ä¸è™šæ­¤è¡Œå¬å¸ƒå¿<!-- raw HTML omitted -->:æœ‰é“¾æ¥å—<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å›¾1æ˜¯å°ç¬¬å®‰çº³å¤§å­¦å†…çš„ç‹™å‡»æ‰‹ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™æªåŒ…æˆ‘è®¤è¯†ï¼Œæ˜¯eberlestockçš„ï¼Œç¾å›½å†›è­¦ç‹™å‡»æ‰‹å’ŒçŒæ‰‹éƒ½çˆ±ç”¨ï¼Œä¾¿å®œé‡åˆè¶³ã€‚ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hp6ywdujorj20wi14ltp7.jpg%22">https://tvax4.sinaimg.cn/large/639b1bfbly1hp6ywdujorj20wi14ltp7.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRJcfMxu">ğŸ”»å§æ§½ ğŸ”»ç½‘å‹åˆ†äº« [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrjcfmxu/">
    
    
    
    
    
      
    
    ğŸ”»å§æ§½ <!-- raw HTML omitted -->ğŸ”»ç½‘å‹åˆ†äº« <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRJcytVS">ğŸ”»è‰¾å¸ƒæ‹‰å§†æ–¯æ­£åœ¨å‰å¾€è«æ–¯ç§‘ï¼ğŸ”»via vk/warhistoryalconafter åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrjcytvs/">
    
    
    
    
    
      
    
    ğŸ”»è‰¾å¸ƒæ‹‰å§†æ–¯æ­£åœ¨å‰å¾€è«æ–¯ç§‘ï¼<!-- raw HTML omitted -->ğŸ”»via vk/warhistoryalconafter <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/HTnhOt6">https://f.video.weibocdn.com/o0/HTnhOt6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObROSwzJO">ğŸ”»é˜¿æ ¹å»·çš„é€šè´§è†¨èƒ€ç‡ç°åœ¨æ¯”å§”å†…ç‘æ‹‰é«˜ 4 å€ã€‚ğŸ”»287% ğŸ‡¦ğŸ‡· ğŸ”»68% ğŸ‡»ğŸ‡ª ğŸ”»æ™šå®‰ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obroswzjo/">
    
    
    
    
    
      
    
    ğŸ”»é˜¿æ ¹å»·çš„é€šè´§è†¨èƒ€ç‡ç°åœ¨æ¯”å§”å†…ç‘æ‹‰é«˜ 4 å€ã€‚<!-- raw HTML omitted -->ğŸ”»287% ğŸ‡¦ğŸ‡· <!-- raw HTML omitted -->ğŸ”»68% ğŸ‡»ğŸ‡ª <!-- raw HTML omitted -->ğŸ”»æ™šå®‰ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRPxD7WP">500åˆ€çš„å¤§çŒåŒ…åœ¨åŒ—ç¾æ‰“çŒè£…å¤‡é‡Œå½“ç„¶ç®—ä¾¿å®œï¼Œåˆ«çœ‹tbçš„ä»·æ ¼ã€‚//@é£ä¸­ä»“é¼ :è¿™å«ä¾¿å®œï¼Ÿ è¯„è®ºé…å›¾ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å›¾1æ˜¯å°ç¬¬å®‰çº³å¤§å­¦å†…çš„ç‹™å‡»æ‰‹ã€‚...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrpxd7wp/">
    
    
    
    
    
      
    
    500åˆ€çš„å¤§çŒåŒ…åœ¨åŒ—ç¾æ‰“çŒè£…å¤‡é‡Œå½“ç„¶ç®—ä¾¿å®œï¼Œåˆ«çœ‹tbçš„ä»·æ ¼ã€‚//<!-- raw HTML omitted -->@é£ä¸­ä»“é¼ <!-- raw HTML omitted -->:è¿™å«ä¾¿å®œï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¯„è®ºé…å›¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å›¾1æ˜¯å°ç¬¬å®‰çº³å¤§å­¦å†…çš„ç‹™å‡»æ‰‹ã€‚&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRPZ2Igm">è‡ªé‡å¤ªå¤§äº†ï¼ŒåŒ…å†…å¤–åŸºæœ¬éƒ½æ˜¯ä¸¤å±‚ç”šè‡³ä¸‰å±‚ç¼åˆ¶ï¼Œç™»å±±ä¸å¥½ä½¿ã€‚//@ä¸è™šæ­¤è¡Œå¬å¸ƒå¿:ç™»å±±å•Š[äºŒå“ˆ]//@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:ä½ åˆä¸æ‰“çŒä½ è¦é“¾æ¥å¹²ä»€ä¹ˆï¼Ÿ//@ä¸è™šæ­¤è¡Œå¬å¸ƒå¿:æœ‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrpz2igm/">
    
    
    
    
    
      
    
    è‡ªé‡å¤ªå¤§äº†ï¼ŒåŒ…å†…å¤–åŸºæœ¬éƒ½æ˜¯ä¸¤å±‚ç”šè‡³ä¸‰å±‚ç¼åˆ¶ï¼Œç™»å±±ä¸å¥½ä½¿ã€‚//<!-- raw HTML omitted -->@ä¸è™šæ­¤è¡Œå¬å¸ƒå¿<!-- raw HTML omitted -->:ç™»å±±å•Š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:ä½ åˆä¸æ‰“çŒä½ è¦é“¾æ¥å¹²ä»€ä¹ˆï¼Ÿ//<!-- raw HTML omitted -->@ä¸è™šæ­¤è¡Œå¬å¸ƒå¿<!-- raw HTML omitted -->:æœ‰é“¾æ¥å—&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRz3e450">é¡¶ç€å‡ æ ¹è‚‹éª¨éª¨æŠ˜å‡ºé™¢äº†ï¼Œç°åœ¨è¿™èŠ‚éª¨çœ¼ä¸æ•¢èººã€‚//@åšæ‰‹çƒ«ä¼¤:æœ¬æ ¼ç»´å°”ä¸æ˜¯è¿˜åœ¨åŒ»é™¢ï¼Ÿå†…å¡”æŠ“ä½æ—¶é—´å·®èµ¶ç´§æŠŠåè®®ç­¾äº†[æ€’] - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ç°åœ¨ä»¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrz3e450/">
    
    
    
    
    
      
    
    é¡¶ç€å‡ æ ¹è‚‹éª¨éª¨æŠ˜å‡ºé™¢äº†ï¼Œç°åœ¨è¿™èŠ‚éª¨çœ¼ä¸æ•¢èººã€‚//<!-- raw HTML omitted -->@åšæ‰‹çƒ«ä¼¤<!-- raw HTML omitted -->:æœ¬æ ¼ç»´å°”ä¸æ˜¯è¿˜åœ¨åŒ»é™¢ï¼Ÿå†…å¡”æŠ“ä½æ—¶é—´å·®èµ¶ç´§æŠŠåè®®ç­¾äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ç°åœ¨ä»¥è‰²åˆ—çš„æƒ…å†µæ˜¯ï¼šæœ¬å°¼ç”˜èŒ¨ã€æœ¬æ ¼ç»´å°”å’Œæ–¯è«ç‰¹é‡Œå¥‡æ­£åœ¨æ”»å‡»å†…å¡”å°¼äºšèƒ¡ï¼Œå¨èƒå†…å¡”å°¼äºšèƒ¡è¦æ˜¯æŒ‰ç…§â€œåŸƒåŠå¤§çº²â€å’Œå“ˆé©¬æ–¯è°ˆåˆ¤å°±è¦æ¨åŠ¨è§£æ•£ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObRzhCbX0">ğŸ”»é˜¿è”é…‹è¿ªæ‹œæ”¿åºœä»Šå¤©æ‰¹å‡†äº†é˜¿å‹’é©¬å…‹å›¾å§†å›½é™…æœºåœºæ–°èˆªç«™æ¥¼çš„è®¾è®¡ï¼Œå¹¶ä¸‹ä»¤ç«‹å³å¼€å§‹å»ºè®¾è€—èµ„ 1280 äº¿è¿ªæ‹‰å§†ï¼ˆ348.54äº¿ç¾å…ƒï¼‰çš„èˆªç«™æ¥¼ã€‚ğŸ”»é˜¿å‹’é©¬å…‹å›¾å§†å›½é™…æœºåœº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obrzhcbx0/">
    
    
    
    
    
      
    
    ğŸ”»é˜¿è”é…‹è¿ªæ‹œæ”¿åºœä»Šå¤©æ‰¹å‡†äº†é˜¿å‹’é©¬å…‹å›¾å§†å›½é™…æœºåœºæ–°èˆªç«™æ¥¼çš„è®¾è®¡ï¼Œå¹¶ä¸‹ä»¤ç«‹å³å¼€å§‹å»ºè®¾è€—èµ„ 1280 äº¿è¿ªæ‹‰å§†ï¼ˆ348.54äº¿ç¾å…ƒï¼‰çš„èˆªç«™æ¥¼ã€‚<!-- raw HTML omitted -->ğŸ”»é˜¿å‹’é©¬å…‹å›¾å§†å›½é™…æœºåœºå°†æˆä¸ºä¸–ç•Œä¸Šæœ€å¤§çš„æœºåœºï¼Œè¯¥æœºåœºå°†æœ‰400ä¸ªé£æœºç™»æœºå£å’Œäº”æ¡å¹³è¡Œè·‘é“ï¼Œæœ€ç»ˆååé‡ä¸º2.6äº¿äººæ¬¡ã€‚è¿™å°†æ˜¯ç›®å‰è¿ªæ‹œå›½é™…æœºåœºçš„äº”å€ã€‚æœªæ¥å‡ å¹´ï¼ŒDXBçš„æ‰€æœ‰ä¸šåŠ¡éƒ½å°†è½¬ç§»åˆ°è¿ªæ‹œå›½é™…æœºåœºã€‚<!-- raw HTML omitted -->ğŸ”»æ–°å¥‡è§‚ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hp6yibod11j20sg0zkqla.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1hp6yibod11j20sg0zkqla.jpg&quot;</a> referrerpolicy=&ldquo;no-referrer&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObNjF9Jke">å››èˆäº”å…¥ä¹Ÿç®—æ˜¯åƒäº†çƒ¤é›ªè±¹ğŸ‘¿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obnjf9jke/">
    
    
    
    
    
      
    
    å››èˆäº”å…¥ä¹Ÿç®—æ˜¯åƒäº†çƒ¤é›ªè±¹ğŸ‘¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObN0Or7GI">åäº† æˆ‘å‰‘ç½‘ä¸‰æœ‰ç˜¾äº†å®Œäº†å®Œäº†å®Œäº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obn0or7gi/">
    
    
    
    
    
      
    
    åäº† æˆ‘å‰‘ç½‘ä¸‰æœ‰ç˜¾äº†å®Œäº†å®Œäº†å®Œäº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObNMLoYP5">æˆ‘çˆ¹è¯´å«æˆ‘æŠŠåœ°æ‰«äº†ï¼Œæˆ‘è¯´è®©æœºå™¨äººæ‰«ï¼Œå±…ç„¶è¿˜é—®æˆ‘è¯´æœºå™¨äººå“ªé‡Œä¼šæ‰«å¾—å¹²å‡€[ä¸¾è½¦]å¤ªç‚¸è£‚äº† - è½¬å‘ @å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡:&amp;ensp;æˆ‘æœ‰æ—¶å€™çœŸçš„è§‰å¾—æˆ‘çˆ¸æœ‰ç—…ä¹°äº†æ‰«åœ°æœºå™¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obnmloyp5/">
    
    
    
    
    
      
    
    æˆ‘çˆ¹è¯´å«æˆ‘æŠŠåœ°æ‰«äº†ï¼Œæˆ‘è¯´è®©æœºå™¨äººæ‰«ï¼Œå±…ç„¶è¿˜é—®æˆ‘è¯´æœºå™¨äººå“ªé‡Œä¼šæ‰«å¾—å¹²å‡€<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å¤ªç‚¸è£‚äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡<!-- raw HTML omitted -->:â€‚æˆ‘æœ‰æ—¶å€™çœŸçš„è§‰å¾—æˆ‘çˆ¸æœ‰ç—…<!-- raw HTML omitted -->ä¹°äº†æ‰«åœ°æœºå™¨äººæŠŠå®ƒç”µæ‹”äº†ç„¶åå«æˆ‘è¿‡å»åšå«ç”Ÿ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObNzkngT8">æˆ‘æœ‰æ—¶å€™çœŸçš„è§‰å¾—æˆ‘çˆ¸æœ‰ç—…ä¹°äº†æ‰«åœ°æœºå™¨äººæŠŠå®ƒç”µæ‹”äº†ç„¶åå«æˆ‘è¿‡å»åšå«ç”Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obnzkngt8/">
    
    
    
    
    
      
    
    æˆ‘æœ‰æ—¶å€™çœŸçš„è§‰å¾—æˆ‘çˆ¸æœ‰ç—…<!-- raw HTML omitted -->ä¹°äº†æ‰«åœ°æœºå™¨äººæŠŠå®ƒç”µæ‹”äº†ç„¶åå«æˆ‘è¿‡å»åšå«ç”Ÿ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObPjVukY6">å®è´é¢†å¸¦æ¢ä¸€æ¡[è€å¸ˆçˆ±ä½ ] - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .ğŸ‘”ğŸ‘”ğŸ‘” [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obpjvuky6/">
    
    
    
    
    
      
    
    å®è´é¢†å¸¦æ¢ä¸€æ¡<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_s">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObPmTATju">å¤´å‘é•¿é•¿ğŸ¥¹ - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ âœ¨ä¹ƒæœ¨ã®ã®é€šçŸ¥âœ¨ä»Šå¤©çš„èŠ‚ç›®ç”±è…åŸå’²æœˆï¼ˆMCï¼‰å’Œé»‘è§æ˜é¦™ä¸ºå¤§å®¶é€ä¸ŠğŸŒ™âš¾ä¹Ÿåˆ†äº«äº†ä¸¤äººæœ€è¿‘çš„ç–å¿½å°æ•…äº‹âœ¨ä¸‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obpmtatju/">
    
    
    
    
    
      
    
    å¤´å‘é•¿é•¿ğŸ¥¹<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->âœ¨ä¹ƒæœ¨ã®ã®é€šçŸ¥âœ¨<!-- raw HTML omitted --><!-- raw HTML omitted -->ä»Šå¤©çš„èŠ‚ç›®ç”±è…åŸå’²æœˆï¼ˆMCï¼‰å’Œé»‘è§æ˜é¦™ä¸ºå¤§å®¶é€ä¸ŠğŸŒ™âš¾<!-- raw HTML omitted -->ä¹Ÿåˆ†äº«äº†ä¸¤äººæœ€è¿‘çš„ç–å¿½å° &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObPnN82jQ">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeen blogå¤§å®¶å¥½ï¼Œæˆ‘æ˜¯ä¹…ä¿å²ç»ªé‡Œã€‚è¿™å°†æ˜¯æˆ‘æœ€åä¸€æ¬¡åœ¨Seventeenä¸Šå†™åšå®¢ï¼Œæˆ‘å°†ä»Seventeenæ¯•ä¸šã€‚6å¹´é›¶7...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obpnn82jq/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObR7RnJAZ">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.nogizaka46 X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obr7rnjaz/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogizaka46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hp6sj71yfcj31kw16oq82.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hp6sj71yfcj31kw16oq82.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObRV3crMc">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä½œä¸º17æ‚æ¨¡ç‰¹æ›´æ–°äº†æœ€åçš„åšå®¢ã€‚åŒ…å«äº†æ„Ÿè°¢ã€ä¸€ç›´ä»¥æ¥çš„å¿ƒæƒ…å’Œçˆ±æ„ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obrv3crmc/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigra">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigra</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObRV5pjX5">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ17ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obrv5pjx5/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->17ins <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObO9JE4aE">è½‰ç™¼å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeen blogå¤§å®¶å¥½ï¼Œæˆ‘æ˜¯ä¹…ä¿å²ç»ªé‡Œã€‚è¿™å°†æ˜¯æˆ‘æœ€åä¸€æ¬¡åœ¨Seventeenä¸Šå†™åšå®¢ï¼Œæˆ‘å°†ä»Seventeenæ¯•ä¸šã€‚6å¹´é›¶7...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obo9je4ae/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObPtLDwli">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .ğŸ‘”ğŸ‘”ğŸ‘” [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obptldwli/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObPtPbmtQ">è½¬å‘å¾®åš - è½¬å‘ @éˆ´æœ¨çµ¢éŸ³å­—å¹•çµ„:&amp;ensp;é“ƒæœ¨ç»šéŸ³#éˆ´æœ¨çµ¢éŸ³#via.CBCå¹¿æ’­ã€Œå¤§æ´¥åŠŸ ã¨ éˆ´æœ¨çµ¢éŸ³ ã®é€šã«ãªã‚ŠãŸã€œã„ï¼ã€å®˜æ–¹X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obptpbmtq/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@éˆ´æœ¨çµ¢éŸ³å­—å¹•çµ„<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->é“ƒæœ¨ç»šéŸ³<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%88%B4%E6%9C%A8">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%88%B4%E6%9C%A8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObQfwbO3f">åˆ†äº«å›¾ç‰‡ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obqfwbo3f/">
    
    
    
    
    
      
    
    åˆ†äº«å›¾ç‰‡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObPJ02eex">å…¬å¸é‡Œçš„äººï¼Œæœ‰çš„å¤©å¤©åŠ ç­å¿™çš„ä¸è¡Œï¼Œè¿˜æœ‰äººå¤©å¤©ç¡è§‰å‡†æ—¶ä¸‹ç­ï¼Œå…¬å¸å°±è¿™ä¹ˆå‡ ä¸ªäººï¼Œè¿™ç§æƒ…å†µä¸‹ä¸ºä»€ä¹ˆè¿˜ä¼šæ€ªåˆ°å‘˜å·¥å¤´ä¸Šï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obpj02eex/">
    
    
    
    
    
      
    
    å…¬å¸é‡Œçš„äººï¼Œæœ‰çš„å¤©å¤©åŠ ç­å¿™çš„ä¸è¡Œï¼Œè¿˜æœ‰äººå¤©å¤©ç¡è§‰å‡†æ—¶ä¸‹ç­ï¼Œå…¬å¸å°±è¿™ä¹ˆå‡ ä¸ªäººï¼Œè¿™ç§æƒ…å†µä¸‹ä¸ºä»€ä¹ˆè¿˜ä¼šæ€ªåˆ°å‘˜å·¥å¤´ä¸Šï¼Ÿ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObRKyuNsA">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šåˆ†å‡ºé«˜ä¸‹çš„é•°ä»“åç•ªæ£‹â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº017ã€‹ #å›´æ£‹# å›´æ£‹ åˆ†å‡ºé«˜ä¸‹çš„é•°ä»“åç•ªæ£‹â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº017 [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obrkyunsa/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šåˆ†å‡ºé«˜ä¸‹çš„é•°ä»“åç•ªæ£‹â€”â€”æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº017ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObO88kS1C">ä¹…ä¿å²ç»ªé‡Œvia.seventeen blogå¤§å®¶å¥½ï¼Œæˆ‘æ˜¯ä¹…ä¿å²ç»ªé‡Œã€‚è¿™å°†æ˜¯æˆ‘æœ€åä¸€æ¬¡åœ¨Seventeenä¸Šå†™åšå®¢ï¼Œæˆ‘å°†ä»Seventeenæ¯•ä¸šã€‚6å¹´é›¶7ä¸ªæœˆï¼ŒçœŸçš„éå¸¸æ„Ÿè°¢å¤§å®¶ã€‚æˆ‘åŠ å…¥æ—¶åª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obo88ks1c/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObPdUgWdz">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .ğŸ‘”ğŸ‘”ğŸ‘” [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obpdugwdz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->.<!-- raw HTML omitted -->ğŸ‘”ğŸ‘”ğŸ‘” &lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObQcLmXHm">ä¹…ä¿å²ç»ªé‡Œvia.nogizaka46 X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obqclmxhm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogizaka46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObRLGwGA4">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä½œä¸º17æ‚æ¨¡ç‰¹æ›´æ–°äº†æœ€åçš„åšå®¢ã€‚åŒ…å«äº†æ„Ÿè°¢ã€ä¸€ç›´ä»¥æ¥çš„å¿ƒæƒ…å’Œçˆ±æ„ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obrlgwga4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObRQx77rh">ä¹…ä¿å²ç»ªé‡Œ17ins é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obrqx77rh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->17ins <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_ca">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_ca</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/363311417/answer/3481659454">çŒ«å“¥çš„è§†ç•Œå›ç­”äº†é—®é¢˜: ç¾å›½ä¸ºä»€ä¹ˆå°±æ˜¯ä¸æ”¾è¿‡ä¿„ç½—æ–¯ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-363311417-answer-3481659454/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695001516">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å›½äº§GPUé‡å¤§åˆ©å¥½ï¼â€œä¸­å›½è‹±ä¼Ÿè¾¾â€åƒå¡é›†ç¾¤å·²å°±ä½</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695001516/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695052705">é‡å­ä½å‘è¡¨äº†æ–‡ç« : ä¸€é”®æ¢è£…ç¥å™¨çˆ†ç«ï¼Œè€é»„æ¢ä¸ŠæŠ±æŠ±è„¸Tæ¤ï¼ŒCEOæœ¬äººï¼šæˆ‘è¢«æ›¿ä»£äº†ï¼Œå’Œä»–äº‰CEOèŒä½äº‰ä¸è¿‡</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695052705/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695077270">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å›½äº§å¤šæ¨¡æ€å¤§æ¨¡å‹å¼€æºï¼æ— æ¡ä»¶å…è´¹å•†ç”¨ï¼Œæ€§èƒ½è¶…Claude 3 Sonnet</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695077270/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695091742">é‡å­ä½å‘è¡¨äº†æ–‡ç« : äººå·¥å‡ åä¸‡ï¼ŒAIå‡ åå—ï¼å›½äº§ç©å®¶è¯æ˜äº†AIGCè§†é¢‘å•†ä¸šåŒ–å¨åŠ›</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695091742/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/695094298">é‡å­ä½å‘è¡¨äº†æ–‡ç« : çªå‘ï¼è°·æ­ŒPythonå›¢é˜Ÿè§£æ•£ï¼ŒPyTorchä¹‹çˆ¶éœ‡æƒŠ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-28</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-695094298/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38671645/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Clinical Relevance of Pathological Diagnosis of Hirschsprung&#39;s Disease with Acetylcholine-Esterase Histochemistry or Calretinin Immunohistochemistry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38671645-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The ability of calretinin IHC to diagnose HD early and time-independently prevented repeated intestinal biopsies in our patient population and allowed us to perform a one-stage TERPT in the first months of life, reducing the number of enterostomies and restoring colonic continuity early. Patients undergoing transanal pull-through under the age of 3 months require a close follow-up to detect cases with bowel movement &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38671815/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Finite Element Analysis of Fixed Orthodontic Retainers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38671815-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The efficacy of retainers is a pivotal concern in orthodontic care. This study examined the biomechanical behaviour of retainers, particularly the influence of retainer stiffness and tooth resilience on force transmission and stress distribution. To do this, a finite element model was created of the lower jaw from the left to the right canine with a retainer attached on the oral side. Three levels of tooth resilience and variable retainer bending stiffness (influenced by retainer type, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672422/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672422-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Alcohol-associated liver disease (ALD) is a substantial cause of morbidity and mortality worldwide and represents a spectrum of liver injury beginning with hepatic steatosis (fatty liver) progressing to inflammation and culminating in cirrhosis. Multiple factors contribute to ALD progression and disease severity. Here, we overview several crucial mechanisms related to ALD end-stage outcome development, such as epigenetic changes, cell death, hemolysis, hepatic stellate cells activation, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240427180547&amp;v=2.18.0.post9&#43;e462414">GTADC: A Graph-Based Method for Inferring Cell Spatial Distribution in Cancer Tissues</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240427180547-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The heterogeneity of tumors poses a challenge for understanding cell interactions and constructing complex ecosystems within cancer tissues. Current research strategies integrate spatial transcriptomics (ST) and single-cell sequencing (scRNA-seq) data to thoroughly analyze this intricate system. However, traditional deep learning methods using scRNA-seq data tend to filter differentially expressed genes through statistical methods. In the context of cancer tissues, where cancer cells &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">GTADC: A Graph-Based Method for Inferring Cell Spatial Distribution in Cancer Tissues</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The heterogeneity of tumors poses a challenge for understanding cell interactions and constructing complex ecosystems within cancer tissues. Current research strategies integrate spatial transcriptomics (ST) and single-cell sequencing (scRNA-seq) data to thoroughly analyze this intricate system. However, traditional deep learning methods using scRNA-seq data tend to filter differentially expressed genes through statistical methods. In the context of cancer tissues, where cancer cells &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672572/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672572-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Breast cancer is the leading cause of cancer-related mortality among women in Germany and worldwide. This retrospective claims data analysis utilizing data from AOK Baden-Wuerttemberg, a major statutory German health insurance provider, aimed to construct and assess a real-world data breast cancer disease model. The study included 27,869 female breast cancer patients and 55,738 age-matched controls, analyzing data from 2010 to 2020. Three distinct breast cancer stages were analyzed: Stage &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672579/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672579-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our results demonstrate the cytotoxic efficacy of helium ion radiotherapy in pancreatic cancer in vitro as well as the capability of mMKM calculation and its value for biological plan optimization in helium ion therapy for pancreatic cancer. A combined treatment of helium irradiation and chemotherapy with gemcitabine leads to mainly additive cytotoxic effects in pancreatic cancer cell lines. The data generated in this study may serve as the radiobiological basis for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672669/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672669-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cytoreductive surgery (CRS) combined with hyperthermic intrathoracic chemoperfusion (HITOC) is a promising treatment strategy for pleural mesothelioma (PM). The aim of this study was to evaluate the impacts of this multimodal approach in combination with systemic treatment on disease-free survival (DFS) and overall survival (OS). In this retrospective multicenter study, clinical data from patients after CRS and HITOC for PM at four high-volume thoracic surgery departments in Germany &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38672680/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38672680-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chimeric antigen receptor (CAR) T-cell therapy has become a powerful treatment option in B-cell and plasma cell malignancies, and many patients have benefited from its use. To date, six CAR T-cell products have been approved by the FDA and EMA, and many more are being developed and investigated in clinical trials. The whole field of adoptive cell transfer has experienced an unbelievable development process, and we are now at the edge of a new era of immune therapies that will have its &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673467/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Comparison between Invasive Intervention and Conservative Treatment in Patients with In-Hospital Myocardial Infarctions: Results from the Regional Myocardial Infarction Registry of Saxony-Anhalt (RHESA) Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673467-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background/Objectives: In-hospital myocardial infarctions (AMIs) are less often treated with invasive intervention, compared to out-of-hospital AMIs. We aimed to identify the determinants of invasive intervention in patients with in-hospital AMIs and assess its association with mortality, compared to conservative treatment. Methods: This was a cross-sectional study of in-hospital AMIs in The Regional Myocardial Infarction Registry of Saxony-Anhalt. Patients' characteristics and outcomes &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673530/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673530-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Introduction: Cardiac transthyretin amyloidosis (ATTR) is a progressive, fatal disease leading to heart failure due to accumulation of amyloid fibrils in the interstitial space and may occur as a hereditary (ATTRv) or wild-type (ATTRwt) form. Guidelines recommend the use of ACE inhibitors (ACEis) and beta-blockers (BBs) as heart failure therapy (HFT) in all patients with symptomatic heart failure and reduced ejection fraction, independent of the underlying etiology. However, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">The General Movement Optimality Score-Revised (GMOS-R) with Socioeconomically Stratified Percentile Ranks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The general movement optimality score (GMOS) quantifies the details of general movements (GMs). We recently conducted psychometric analyses of the GMOS and developed a revised scoresheet. Consequently, the GMOS-Revised (GMOS-R) instrument necessitated validation using new percentile ranks. This study aimed to provide these percentile ranks for the GMOS-R and to investigate whether sex, preterm birth, or the infant&rsquo;s country of birth and residence affected the GMOS-R &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">The General Movement Optimality Score-Revised (GMOS-R) with Socioeconomically Stratified Percentile Ranks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The general movement optimality score (GMOS) quantifies the details of general movements (GMs). We recently conducted psychometric analyses of the GMOS and developed a revised scoresheet. Consequently, the GMOS-Revised (GMOS-R) instrument necessitated validation using new percentile ranks. This study aimed to provide these percentile ranks for the GMOS-R and to investigate whether sex, preterm birth, or the infant&rsquo;s country of birth and residence affected the GMOS-R &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673751/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673751-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Plant-derived multitarget compounds may represent a promising therapeutic strategy for multifactorial diseases, such as Alzheimer&rsquo;s disease (AD). Artemisinin and its derivatives were indicated to beneficially modulate various aspects of AD pathology in different AD animal models through the regulation of a wide range of different cellular processes, such as energy homeostasis, apoptosis, proliferation and inflammatory pathways. In this review, we aimed to provide an up-to-date overview of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38673751/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38673751-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Plant-derived multitarget compounds may represent a promising therapeutic strategy for multifactorial diseases, such as Alzheimer&rsquo;s disease (AD). Artemisinin and its derivatives were indicated to beneficially modulate various aspects of AD pathology in different AD animal models through the regulation of a wide range of different cellular processes, such as energy homeostasis, apoptosis, proliferation and inflammatory pathways. In this review, we aimed to provide an up-to-date overview of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240427180547&amp;v=2.18.0.post9&#43;e462414">Graph Node Classification to Predict Autism Risk in Genes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240427180547-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study explores the genetic risk associations with autism spectrum disorder (ASD) using graph neural networks (GNNs), leveraging the Sfari dataset and protein interaction network (PIN) data. We built a gene network with genes as nodes, chromosome band location as node features, and gene interactions as edges. Graph models were employed to classify the autism risk associated with newly introduced genes (test set). Three classification tasks were undertaken to test the ability of our &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">Graph Node Classification to Predict Autism Risk in Genes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study explores the genetic risk associations with autism spectrum disorder (ASD) using graph neural networks (GNNs), leveraging the Sfari dataset and protein interaction network (PIN) data. We built a gene network with genes as nodes, chromosome band location as node features, and gene interactions as edges. Graph models were employed to classify the autism risk associated with newly introduced genes (test set). Three classification tasks were undertaken to test the ability of our &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674841/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674841-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Osteoporosis affects one in three women over the age of 50 and results in fragility fractures. Oestrogen deficiency during and after menopause exacerbates bone loss, accounting for higher prevalence of fragility fractures in women. The gut microbiota (GM) has been proposed as a key regulator of bone health, as it performs vital functions such as immune regulation and biosynthesis of vitamins. Therefore, GM modulation via probiotic supplementation has been proposed as a target for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38674841/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">The Effectiveness of a Lactobacilli-Based Probiotic Food Supplement on Bone Mineral Density and Bone Metabolism in Australian Early Postmenopausal Women: Protocol for a Double-Blind Randomized Placebo-Controlled Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38674841-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Osteoporosis affects one in three women over the age of 50 and results in fragility fractures. Oestrogen deficiency during and after menopause exacerbates bone loss, accounting for higher prevalence of fragility fractures in women. The gut microbiota (GM) has been proposed as a key regulator of bone health, as it performs vital functions such as immune regulation and biosynthesis of vitamins. Therefore, GM modulation via probiotic supplementation has been proposed as a target for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675472/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675472-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    [^(177)Lu]Lu-PSMA-617 has recently been successfully approved by the FDA, the MHRA, Health Canada and the EMA as Pluvicto^(Â®). However, salivary gland (SG) and kidney toxicities account for its main dose-limiting side-effects, while its corresponding uptake and retention mechanisms still remain elusive. Recently, the presence of different ATP-binding cassette (ABC) transporters, such as human breast cancer resistance proteins (BCRP), multidrug resistance proteins &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675472/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675472-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    [^(177)Lu]Lu-PSMA-617 has recently been successfully approved by the FDA, the MHRA, Health Canada and the EMA as Pluvicto^(Â®). However, salivary gland (SG) and kidney toxicities account for its main dose-limiting side-effects, while its corresponding uptake and retention mechanisms still remain elusive. Recently, the presence of different ATP-binding cassette (ABC) transporters, such as human breast cancer resistance proteins (BCRP), multidrug resistance proteins &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675604/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240427180547&amp;v=2.18.0.post9&#43;e462414">BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675604-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240427180547-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Detecting the unintended adverse reactions of drugs (ADRs) is a crucial concern in pharmacological research. The experimental validation of drug-ADR associations often entails expensive and time-consuming investigations. Thus, a computational model to predict ADRs from known associations is essential for enhanced efficiency and cost-effectiveness. Here, we propose BiMPADR, a novel model that integrates drug gene expression into adverse reaction features using a message passing neural network &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675604/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675604-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Detecting the unintended adverse reactions of drugs (ADRs) is a crucial concern in pharmacological research. The experimental validation of drug-ADR associations often entails expensive and time-consuming investigations. Thus, a computational model to predict ADRs from known associations is essential for enhanced efficiency and cost-effectiveness. Here, we propose BiMPADR, a novel model that integrates drug gene expression into adverse reaction features using a message passing neural network &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675779/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675779-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is one of the most common cancers among women and the most lethal malignancy of all gynecological cancers. Surgery is promising in the early stages; however, most patients are first diagnosed in the advanced stages, where treatment options are limited. Here, we present a 49-year-old patient who was first diagnosed with stage III ovarian cancer. After the tumor progressed several times under guideline therapies with no more treatment options available at that time, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675779/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675779-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is one of the most common cancers among women and the most lethal malignancy of all gynecological cancers. Surgery is promising in the early stages; however, most patients are first diagnosed in the advanced stages, where treatment options are limited. Here, we present a 49-year-old patient who was first diagnosed with stage III ovarian cancer. After the tumor progressed several times under guideline therapies with no more treatment options available at that time, the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nanoparticles show great promise as a platform for developing vaccines for the prevention of infectious disease. We have been investigating a method whereby nanocapsules can be formulated from protein, such that the final capsules contain only the cross-linked protein itself. Such nanocapsules are made using a silica templating system and can be customised in terms of size and porosity. Here we compare the construction and characteristics of nanocapsules from four different proteins: one a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675791/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675791-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nanoparticles show great promise as a platform for developing vaccines for the prevention of infectious disease. We have been investigating a method whereby nanocapsules can be formulated from protein, such that the final capsules contain only the cross-linked protein itself. Such nanocapsules are made using a silica templating system and can be customised in terms of size and porosity. Here we compare the construction and characteristics of nanocapsules from four different proteins: one a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675973/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240427180604&amp;v=2.18.0.post9&#43;e462414">DMSO and Its Role in Differentiation Impact Efficacy of Human Adenovirus (HAdV) Infection in HepaRG Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675973-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240427180604-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Differentiated HepaRG cells are popular in vitro cell models for hepatotoxicity studies. Their differentiation is usually supported by the addition of dimethyl sulfoxide (DMSO), an amphipathic solvent widely used in biomedicine, for example, in potential novel therapeutic drugs and cryopreservation of oocytes. Recent studies have demonstrated drastic effects, especially on epigenetics and extracellular matrix composition, induced by DMSO, making its postulated inert character doubtful. In &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38675973/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">DMSO and Its Role in Differentiation Impact Efficacy of Human Adenovirus (HAdV) Infection in HepaRG Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38675973-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Differentiated HepaRG cells are popular in vitro cell models for hepatotoxicity studies. Their differentiation is usually supported by the addition of dimethyl sulfoxide (DMSO), an amphipathic solvent widely used in biomedicine, for example, in potential novel therapeutic drugs and cryopreservation of oocytes. Recent studies have demonstrated drastic effects, especially on epigenetics and extracellular matrix composition, induced by DMSO, making its postulated inert character doubtful. In &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676549/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Validation of a Simple Clinical Tool for Screening of Acute Lacunar Stroke - a substudy of the WAKE-UP trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676549-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Lacunar score had a very good specificity and NPV for screening of lacunar stroke. Implementation of this simple tool into clinical practice may help hyperacute management and guide patient selection in clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676601/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Temporal Association Between Atrial Fibrillation and Ischemic Stroke: Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676601-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This meta-analysis supports a temporal relationship between PAF and ischemic stroke within a 30-day window. Establishing this relationship is important for individualized risk prediction and targeted anticoagulation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676623/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676623-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    RATIONALE: A large proportion of stroke survivors will have long-lasting, debilitating neurological impairments, yet few efficacious medical treatment options are available. Etanercept inhibits binding of tumor necrosis factor to its receptor and is used in the treatment of inflammatory conditions. Perispinal subcutaneous injection followed by a supine, head down position may bypass the blood brain barrier. In observational studies and one small randomized controlled trial the majority &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676626/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676626-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MicroRNAs (miRNAs) are a subset of small non-coding single-stranded RNA molecules involved in the regulation of post-transcriptional gene expression of a variety of transcript targets. Therefore altered miRNA expression may result in the dysregulation of key genes and biological pathways that has been reported with the onset and progression of neurodegenerative diseases, such as Amyotrophic lateral sclerosis (ALS). ALS is marked by a progressive degeneration of motor neurons (MNs) present in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676804/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676804-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Colorectal cancer (CRC) is a significant global health concern, requiring effective preclinical models for studying its development and testing therapies. Mouse models have been used, including spontaneous tumors, carcinogen exposure, and tumor cell implantation as xenografts or at orthotopic sites. Here, we describe an orthotopic preclinical model of CRC, which provides a valuable tool for studying tumor growth and the tumor microenvironment, offering a more accurate representation of human &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676844/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">&#34;TiC-TUG&#34;: technology in clinical practice using the instrumented timed up and go test-a scoping review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676844-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Digitized assessments have a considerable potential to guide clinicial decision making and monitor progress and disease trajectories. The Timed Up and Go test (TUG) has been long established for assessment in geriatric medicine and instrumented versions (iTUG) have been developed and validated. This scoping review includes studies that applied the iTUG and aims to identify use cases to show where and how iTUG assessment could guide interventions and clinical management. The literature search &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676911/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Recognizing the opportunity to directly de-label no-risk penicillin allergies in community pharmacy: a mystery shopper experience</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676911-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings underscore a concerning knowledge and practice gap among community pharmacists regarding penicillin allergy assessment which warrants more support and education in the community pharmacy &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240428181057&amp;v=2.18.0.post9&#43;e462414">Emerging immunotherapies in the Hodgkin Lymphoma Armamentarium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676917-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240428181057-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Brentuximab vedotin and the PD-1 inhibitors have improved outcomes for classic Hodgkin lymphoma (cHL), but better therapies are needed for patients who relapse after these agents. Based on improved understanding of cHL biology, there is a robust pipeline of novel therapies in development. In this review, we highlight emerging immunotherapeutic agents and combinations for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38676928/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Protocol for generating and analyzing organ-on-chip using human and mouse intestinal organoids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38676928-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Organ-on-chip technology is a powerful tool for in vitro modeling. Combining it with organoids overcomes lumen inaccessibility while preserving cellular diversity and function of the intestinal epithelium. Here, we present a protocol for generating and analyzing organ-on-chips using human and mouse intestinal organoids. This protocol covers organoid line establishment, single-cell dissociation, chip preparation, and seeding. It outlines procedures for permeability assays, RNA &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677014/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240428181048&amp;v=2.18.0.post9&#43;e462414">POLAT: Protein function prediction based on soft mask graph network and residue-Label ATtention</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677014-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240428181048-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MOTIVATION: Elucidating protein function is a central problem in biochemistry, genetics, and molecular biology. Developing computational methods for protein function prediction is critical due to the significant gap between sequence and functional data. Recent advances in protein structure prediction, which strongly correlates with function, make it feasible to use structure to predict function. However, current structure-based methods overlook the fact that individual residues may &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677039/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Robustness of radiomic features in healthy abdominal parenchyma of patients with repeated examinations on dual-layer dual-energy CT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677039-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Radiomic feature robustness obtained from cancer-free subjects with repeated examinations using a consistent protocol and CT scanner was limited, with first order features yielding the highest proportion of robust &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677380/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Determinants of circulating calcitriol in cardiovascular disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677380-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Circulating calcitriol may contribute to the risk of cardiovascular disease (CVD), but its regulation in patients with CVD is poorly characterized. We therefore aimed to assess determinants of circulating calcitriol in these patients. We analyzed 2183 independent samples from a large cohort of patients scheduled for coronary angiography and 1727 independent samples from different other cohorts from patients with a wide range of CVDs, including heart transplant candidates, to quantify &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38677594/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: data from a practice-based longitudinal cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38677594-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The low CTEPH incidence rate after acute PE in the present analysis suggests low awareness of CTEPH. It further suggests a lack of systematic follow-up protocols for acute PE survivors in the real world. Improved implementation of existing recommendations on follow-up strategies post PE is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38678011/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">Linear interaction between replication and transcription shapes DNA break dynamics at recurrent DNA break Clusters</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38678011-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recurrent DNA break clusters (RDCs) are replication-transcription collision hotspots; many are unique to neural progenitor cells. Through high-resolution replication sequencing and a capture-ligation assay in mouse neural progenitor cells experiencing replication stress, we unravel the replication features dictating RDC location and orientation. Most RDCs occur at the replication forks traversing timing transition regions (TTRs), where sparse replication origins connect unidirectional &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38678102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240428181100&amp;v=2.18.0.post9&#43;e462414">One model to use them all: training a segmentation model with complementary datasets</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38678102-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240428181100-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: By leveraging multiple datasets and applying mutual exclusion constraints, we developed a method that improves surgical scene segmentation performance without the need for fully annotated datasets. Our results demonstrate the feasibility of training a model on multiple complementary datasets. This paves the way for future work further alleviating the need for one specialized large, fully segmented dataset but instead the use of already existing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObCStBIpR">ä»Šå¤©å‚åŠ äº†æˆ‘ä»¬é€‰åŒºä¸€ä¸ªå°æ—¶çš„run for office 101åŸ¹è®­ï¼ŒNPRä¹‹å‰ä¹Ÿæœ‰ç±»ä¼¼çš„èŠ‚ç›®ï¼Œä½†æˆ‘ä»¬é€‰åŒºåŠçš„æ›´æœ‰æœ¬é€‰åŒºé’ˆå¯¹æ€§ã€‚è¿›è¡ŒåŸ¹è®­çš„æœ‰Palo Alto city councilï¼Œæ›´æœ‰ä»£...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obcstbipr/">
    
    
    
    
    
      
    
    ä»Šå¤©å‚åŠ äº†æˆ‘ä»¬é€‰åŒºä¸€ä¸ªå°æ—¶çš„run for office 101åŸ¹è®­ï¼ŒNPRä¹‹å‰ä¹Ÿæœ‰ç±»ä¼¼çš„èŠ‚ç›®ï¼Œä½†æˆ‘ä»¬é€‰åŒºåŠçš„æ›´æœ‰æœ¬é€‰åŒºé’ˆå¯¹æ€§ã€‚è¿›è¡ŒåŸ¹è®­çš„æœ‰Palo Alto city councilï¼Œæ›´æœ‰ä»£è¡¨äº†ä¸€ç™¾ä¸‡äººçš„åŠ å·å·å‚è®®å‘˜Josh Beckerã€‚æ‰€ä»¥æˆ‘è§‰å¾—åŠ å·çš„elected officialsæ¯”ä¸œæµ·å²¸è¦å¹³æ˜“è¿‘äººå¾ˆå¤šï¼Œå› ä¸ºä½ ç»å¸¸èƒ½åœ¨æ™®é€šé€‰åŒºæ´»åŠ¨ä¸­è§åˆ°ä»–ä»¬ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™ä¸ª101åŸ¹è®­ç‰¹åˆ«å¥½ï¼Œè¯¦ç»†ä»run for school boardåˆ°city councilçš„å…·ä½“ç»†èŠ‚ï¼Œä»æœ€åˆç­¹åˆ’åˆ°å‹Ÿé›†ç­¾åå’Œç­¹æ¬¾ï¼Œåˆ°campaignåœ°ç‚¹é€‰æ‹©ç­‰ï¼›æ›´é‡è¦çš„æ˜¯å¦‚ä½•å¹³è¡¡è‡ªå·±çš„æœ¬èŒå·¥ä½œã€å®¶åº­ç”Ÿæ´»å’Œcampaignã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å¾ˆå¤šäººè¯´politicsæ”¹å˜ä¸äº†è‡ªå·±ç”Ÿæ´»ï¼Œå…¶å®åœ¨ç¾å›½ï¼ŒåŸºå±‚politicså½±å“åˆ°è‡ªå·±ç”Ÿæ´»æ–¹æ–¹é¢é¢ï¼šå“ªé‡Œä¿®è¶…å¸‚ã€å“ªé‡Œå»ºå…»è€é™¢ã€å»ºåœè½¦ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/ObFes01xF">æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2å·²ç»å‡ºç°4å¹´ä¹‹ä¹…ï¼Œå‡ ä¹æ„ŸæŸ“äº†å…¨äººç±»ï¼Œé‚£ä¹ˆåœ¨ç¾¤ä½“å…ç–«å·²ç»å»ºç«‹çš„æƒ…å†µä¸‹ï¼ŒSARS-CoV-2æ„ŸæŸ“ä¼šä¸ä¼šæ›´è½»å¾®å‘¢ï¼Ÿç‰›æ´¥å¤§å­¦PLATCOVç ”ç©¶ç»„åœ¨Lancet I...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obfes01xf/">
    
    
    
    
    
      
    
    æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2å·²ç»å‡ºç°4å¹´ä¹‹ä¹…ï¼Œå‡ ä¹æ„ŸæŸ“äº†å…¨äººç±»ï¼Œé‚£ä¹ˆåœ¨ç¾¤ä½“å…ç–«å·²ç»å»ºç«‹çš„æƒ…å†µä¸‹ï¼ŒSARS-CoV-2æ„ŸæŸ“ä¼šä¸ä¼šæ›´è½»å¾®å‘¢ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted -->ç‰›æ´¥å¤§å­¦PLATCOVç ”ç©¶ç»„åœ¨Lancet IDå‘è¡¨äº†ä¸€é¡¹SARS-CoV-2æ²»ç–—ç ”ç©¶ï¼Œå¯¹å›ç­”ä¸Šè¿°é—®é¢˜å¾ˆæœ‰æ„ä¹‰ã€‚ç ”ç©¶è¯„ä¼°äº†2021å¹´åˆ°2023å¹´å¹´åº•æ„ŸæŸ“SARS-CoV-2åçš„ç–¾ç—…è¿›å±•ï¼ˆNCT05041907ï¼‰ã€‚åœ¨å…¥ç»„çš„1262åå¤šä¸´åºŠä¸­å¿ƒçš„æ‚£è€…ä¸­ï¼Œå‘ç—…7å¤©åï¼Œç—…æ¯’ä¸­ä½æ¸…é™¤æ—¶é—´ä»2021å¹´çš„16.6å°æ—¶ç¼©çŸ­åˆ°äº†2023å¹´çš„9.2å°æ—¶ï¼Œå¯¹äºæœªæ¥å—æŠ—ç—…æ¯’è¯çš„æ‚£è€…è€Œè¨€ï¼Œå…¶7å¤©ç—…æ¯’æ¸…é™¤å‡å°‘44%ï¼›è€Œä½¿ç”¨Paxlovidæ‚£è€…ç—…æ¯’æ¸…é™¤å‡å°‘26%ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™ä¸€æ•°æ®æç¤ºï¼Œæ„ŸæŸ“SARS-CoV-2åæ•´ä½“ç—…æ¯’æ¸…é™¤æ—¶é—´ç¼©çŸ­ã€‚&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/4a994b1dgy1hp5g1ucsiaj217y4dfe81">https://tvax3.sinaimg.cn/large/4a994b1dgy1hp5g1ucsiaj217y4dfe81</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObCQcb0fv">#é©¬ä¹¦è´¦# åœ¨å‰å¾€å—å®çš„ç«è½¦ä¸Šï¼Œçœ‹å®Œäº†è¿™æœ¬ã€Šæ— è´£ä»»çš„å¸å›½-è¿‘ä»£æ—¥æœ¬çš„æ‰©å¼ ä¸æ¯ç­ã€‹ã€‚å¦‚æœ¬ä¹¦ä½œè€…åœ¨å‰è¨€æ‰€è¯´ï¼Œå¯¹äºè¿‘ä»£æ—¥æœ¬ï¼Œæˆ‘ä»¬æ—¢ç†Ÿæ‚‰åˆé™Œç”Ÿã€‚ç†Ÿæ‚‰æ˜¯è¯´æˆ‘ä»¬å¯¹å…¶æ‰€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obcqcb0fv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->#é©¬ä¹¦è´¦#<!-- raw HTML omitted --><!-- raw HTML omitted --> åœ¨å‰å¾€å—å®çš„ç«è½¦ä¸Šï¼Œçœ‹å®Œäº†è¿™æœ¬ã€Šæ— è´£ä»»çš„å¸å›½-è¿‘ä»£æ—¥æœ¬çš„æ‰©å¼ ä¸æ¯ç­ã€‹ã€‚å¦‚æœ¬ä¹¦ä½œè€…åœ¨å‰è¨€æ‰€è¯´ï¼Œå¯¹äºè¿‘ä»£æ—¥æœ¬ï¼Œæˆ‘ä»¬æ—¢ç†Ÿæ‚‰åˆé™Œç”Ÿã€‚ç†Ÿæ‚‰æ˜¯è¯´æˆ‘ä»¬å¯¹å…¶æ‰€ä½œæ‰€ä¸ºè€³ç†Ÿèƒ½è¯¦ï¼Œä¹ƒè‡³äºåˆ»éª¨é“­å¿ƒï¼šä½†å¯¹è¿™äº›è¡Œä¸ºèƒŒåçš„åŠ¨å› ï¼Œå¾€å¾€åªä»¥ä¸€å¥å¸å›½ä¸»ä¹‰ç‹¼å­é‡å¿ƒæ¦‚æ‹¬ä¹‹ï¼Œæœªèƒ½çŸ¥å…¶æ‰€ä»¥ç„¶ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å¤§éƒ¨åˆ†ç›¸å…³ä¸»é¢˜çš„ä¹¦ç±ï¼Œè¦ä¹ˆä¸“æ³¨äºæœï¼Œè®ºè¿°å…¶æ‰©å¼ ä¾µç•¥çš„å…·ä½“å®æ–½è¿‡ç¨‹ï¼›è¦ä¹ˆä¸“æ³¨äºå› ï¼Œè®ºè¿°ç»æµã€å†›äº‹ã€å¤–äº¤ã€å·¥ä¸šç­‰ä¿ƒæˆæ—¥æœ¬æ‰©å¼ çš„å„ç§å®¢è§‚å› ç´ ã€‚è€Œè¿™æœ¬ä¹¦çš„é‡ç‚¹ï¼Œæ°å¥½è½äºå› æœä¹‹é—´ï¼Œè®²è¿°â€œç”±å› åŒ–æœâ€çš„å…·ä½“å†³ç­–è¿‡ç¨‹ã€‚å®ƒé€šè¿‡é’ˆå¯¹ä¸€ä¸ªä¸ªæ”¿æ²» &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/ObE40sRgX">è¿™ä¸ªç”µæ¢¯æç¤ºæœ‰ç‚¹èŒå“ï¼Œæ„Ÿè§‰ä¸€æŒ‰ä¸‹å»å°±ä¼šè­¦é“ƒå¤§ä½œï¼Œå››é¢â€œå”°â€åœ°è½ä¸‹é“æ …æ ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-obe40srgx/">
    
    
    
    
    
      
    
    è¿™ä¸ªç”µæ¢¯æç¤ºæœ‰ç‚¹èŒå“ï¼Œæ„Ÿè§‰ä¸€æŒ‰ä¸‹å»å°±ä¼šè­¦é“ƒå¤§ä½œï¼Œå››é¢â€œå”°â€åœ°è½ä¸‹é“æ …æ ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObICAco2r">ğŸ”»â€¦â€¦ğŸ”»æ¥è‡ªç½‘å‹åˆ†äº«ï¼Œå½“é£é è¿‘æ—¶ï¼Œèƒ½å¬åˆ°å‘¼å•¸å£°ã€‚ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obicaco2r/">
    
    
    
    
    
      
    
    ğŸ”»â€¦â€¦<!-- raw HTML omitted -->ğŸ”»æ¥è‡ªç½‘å‹åˆ†äº«ï¼Œå½“é£é è¿‘æ—¶ï¼Œèƒ½å¬åˆ°å‘¼å•¸å£°ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/HL60LAn0lx08eq6JF">https://f.video.weibocdn.com/o0/HL60LAn0lx08eq6JF</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIeV9KPw">ğŸ”»ä»ç°åœºæ®‹éª¸æ¥çœ‹ï¼Œç¡®å®æ‰“ä¸‹æ¥äº†ã€‚ğŸ”»è¿™ç¾å†›è¢«æ‰“ä¸‹æ¥çš„ç¬¬å‡ æ¶äº†ï¼Ÿ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obiev9kpw/">
    
    
    
    
    
      
    
    ğŸ”»ä»ç°åœºæ®‹éª¸æ¥çœ‹ï¼Œç¡®å®æ‰“ä¸‹æ¥äº†ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™ç¾å†›è¢«æ‰“ä¸‹æ¥çš„ç¬¬å‡ æ¶äº†ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/larg">https://tvax2.sinaimg.cn/larg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIfl6FTF">ğŸ”»CNNï¼šç¾å›½è­¦æ–¹å‘¨å…­æ—©ä¸Šåœ¨æ³¢å£«é¡¿ä¸œåŒ—å¤§å­¦æ ¡å›­æ¸…ç†â€œæœªç»æˆæƒçš„éœ²è¥åœ°â€æ—¶æŠ“èµ°äº†å¤§çº¦100äººã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obifl6ftf/">
    
    
    
    
    
      
    
    ğŸ”»CNNï¼šç¾å›½è­¦æ–¹å‘¨å…­æ—©ä¸Šåœ¨æ³¢å£«é¡¿ä¸œåŒ—å¤§å­¦æ ¡å›­æ¸…ç†â€œæœªç»æˆæƒçš„éœ²è¥åœ°â€æ—¶æŠ“èµ°äº†å¤§çº¦100äººã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIhmsgbO">ğŸ”»ç¾å›½ä¹Ÿæ­£åœ¨åˆ®é¾™å·é£ï¼Œè¿™æ˜¯å¥¥é©¬å“ˆ-åŸƒå°”ç§‘æ©ï¼Œå†…å¸ƒæ‹‰æ–¯åŠ å·ã€‚ğŸ”»via weathernationtv.comğŸ”»è§†é¢‘1æ˜¯ä¸€ä¸ªå±‹ä¸»åœ¨é¾™å·é£è¢­å‡»ä»–å®¶6åˆ†é’Ÿä¹‹å‰æ‹çš„ï¼Œå›¾2-4æ˜¯è¢­å‡»å...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obihmsgbo/">
    
    
    
    
    
      
    
    ğŸ”»ç¾å›½ä¹Ÿæ­£åœ¨åˆ®é¾™å·é£ï¼Œè¿™æ˜¯å¥¥é©¬å“ˆ-åŸƒå°”ç§‘æ©ï¼Œå†…å¸ƒæ‹‰æ–¯åŠ å·ã€‚<!-- raw HTML omitted -->ğŸ”»via weathernationtv.com<!-- raw HTML omitted -->ğŸ”»è§†é¢‘1æ˜¯ä¸€ä¸ªå±‹ä¸»åœ¨é¾™å·é£è¢­å‡»ä»–å®¶6åˆ†é’Ÿä¹‹å‰æ‹çš„ï¼Œå›¾2-4æ˜¯è¢­å‡»åï¼Œè§†é¢‘5æ˜¯æ•´ä¸ªè¡—åŒºçš„æƒ…å†µã€‚<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIhvgUrg">ğŸ”»æœ‰äººæŠ±ç€ä»–çš„ç”»å’Œå£å·ã€‚ğŸ”»æºï¼šqudsnen.co [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obihvgurg/">
    
    
    
    
    
      
    
    ğŸ”»æœ‰äººæŠ±ç€ä»–çš„ç”»å’Œå£å·ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šqudsnen.co <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIi4a9sR">ğŸ”»ç„¶åè€å¸ˆä»¬ç»„æˆäººå¢™çš„å¹¿åœºå°±å˜æˆå›¾2è¿™æ ·äº†ã€‚ğŸ”»ç¾å›½é€Ÿåº¦ã€‚#çº½çº¦å¤§å­¦è€å¸ˆç»„æˆäººå¢™ä¿æŠ¤å­¦ç”Ÿä¸è¢«é€®æ•# [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obii4a9sr/">
    
    
    
    
    
      
    
    ğŸ”»ç„¶åè€å¸ˆä»¬ç»„æˆäººå¢™çš„å¹¿åœºå°±å˜æˆå›¾2è¿™æ ·äº†ã€‚<!-- raw HTML omitted -->ğŸ”»ç¾å›½é€Ÿåº¦ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#çº½çº¦å¤§å­¦è€å¸ˆç»„æˆäººå¢™ä¿æŠ¤å­¦ç”Ÿä¸è¢«é€®æ•#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIiTySMa">ğŸ”»ğŸ‡°ğŸ‡µæœå®£å°å‹çŸ­ç‰‡ï¼šå¹³å£¤ç¬¬ä¸€ç™¾è´§å•†åº—ã€‚ğŸ”»via KCNA åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obiitysma/">
    
    
    
    
    
      
    
    ğŸ”»ğŸ‡°ğŸ‡µæœå®£å°å‹çŸ­ç‰‡ï¼šå¹³å£¤ç¬¬ä¸€ç™¾è´§å•†åº—ã€‚<!-- raw HTML omitted -->ğŸ”»via KCNA <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/tXb4o1x4lx08eq3p3J4">https://f.video.weibocdn.com/o0/tXb4o1x4lx08eq3p3J4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIkJDymG">ğŸ”»Man!ğŸ”»What Can i say? [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obikjdymg/">
    
    
    
    
    
      
    
    ğŸ”»Man!<!-- raw HTML omitted -->ğŸ”»What Can i say? <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIvjEcgH">ä½ éƒ½çœ‹æå”äº†â€¦â€¦//@ç™½æ¡ƒæ‚ ç„¶:è®²çœŸæŠ›å¼€å”‡äº¡é½¿å¯’ï¼Œæˆ‘çœŸè§‰å¾—è¿™ä¸ªå…‰ä¹‹å›½çœŸçš„å¾ˆç±»äººï¼Œä»æå”è®²çš„å…‰ä¹‹å›½å°±å¯¹è¿™ä¸ªæœå®¶æ²¡æœ‰å¥½æ„Ÿï¼Œè¿™å°±æ‰¯å‡ºä¸€ä¸ªé—®é¢˜ï¼Œä½ è®¤ä¸ºç‹¬ç«‹è‡ªä¸»å¾ˆé‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obivjecgh/">
    
    
    
    
    
      
    
    ä½ éƒ½çœ‹æå”äº†â€¦â€¦//<!-- raw HTML omitted -->@ç™½æ¡ƒæ‚ ç„¶<!-- raw HTML omitted -->:è®²çœŸæŠ›å¼€å”‡äº¡é½¿å¯’ï¼Œæˆ‘çœŸè§‰å¾—è¿™ä¸ªå…‰ä¹‹å›½çœŸçš„å¾ˆç±»äººï¼Œä»æå”è®²çš„å…‰ä¹‹å›½å°±å¯¹è¿™ä¸ªæœå®¶æ²¡æœ‰å¥½æ„Ÿï¼Œè¿™å°±æ‰¯å‡ºä¸€ä¸ªé—®é¢˜ï¼Œä½ è®¤ä¸ºç‹¬ç«‹è‡ªä¸»å¾ˆé‡è¦ï¼Œè¿˜æ˜¯äººæ°‘ç”Ÿæ´»å¥½å¾ˆé‡è¦ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ğŸ‡°ğŸ‡µæœå®£å°å‹çŸ­ç‰‡ï¼šå¹³å£¤ç¬¬ä¸€ç™¾è´§å•†åº—ã€‚<!-- raw HTML omitted -->ğŸ”»via KCNA <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/ObIxsy71t">ğŸ”»è¿æ˜Ÿæ˜Ÿéƒ½ä¸çˆ±åƒè¥¿å…°èŠ±ã€‚ğŸ”»åƒç™½äººé¥­çš„æ˜¯æ€ä¹ˆå¿çš„ï¼ŸğŸ”»via å†¯æ¤¿ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obixsy71t/">
    
    
    
    
    
      
    
    ğŸ”»è¿æ˜Ÿæ˜Ÿéƒ½ä¸çˆ±åƒè¥¿å…°èŠ±ã€‚<!-- raw HTML omitted -->ğŸ”»åƒç™½äººé¥­çš„æ˜¯æ€ä¹ˆå¿çš„ï¼Ÿ<!-- raw HTML omitted -->ğŸ”»via å†¯æ¤¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/vih1NA5Yl">https://f.video.weibocdn.com/o0/vih1NA5Yl</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/ObCQ1aA55">åˆ«æ¥è¿™ä¸ªå¾ªç¯äº†æˆ‘çœŸçš„æ˜¯æ€•äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-obcq1aa55/">
    
    
    
    
    
      
    
    åˆ«æ¥è¿™ä¸ªå¾ªç¯äº†æˆ‘çœŸçš„æ˜¯æ€•äº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObENi2N9y">[æ‚²ä¼¤]è¿™æ˜¯é­”æ³• [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obeni2n9y/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™æ˜¯é­”æ³• <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObFBKkGtE">é‡å‘ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obfbkkgte/">
    
    
    
    
    
      
    
    é‡å‘ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObFZctP82">çœŸæ˜¯ç¦æŠ¥ï¼Œæ²¡é’±ä¹Ÿå°±ç®—äº†ï¼Œè¿˜å¾—å€’è´´ä¸ªå¿ƒæƒ…</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obfzctp82/">
    
    
    
    
    
      
    
    çœŸæ˜¯ç¦æŠ¥ï¼Œæ²¡é’±ä¹Ÿå°±ç®—äº†ï¼Œè¿˜å¾—å€’è´´ä¸ªå¿ƒæƒ…  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObGkPEItg">çƒ¤é¸­åŠåªç‚’é¢ä¸€ç›˜å’–å•¡ä¸€æ¯ç•ªèŒ„ä¸¤åª</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obgkpeitg/">
    
    
    
    
    
      
    
    çƒ¤é¸­åŠåª<!-- raw HTML omitted -->ç‚’é¢ä¸€ç›˜<!-- raw HTML omitted -->å’–å•¡ä¸€æ¯<!-- raw HTML omitted -->ç•ªèŒ„ä¸¤åª  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/ObHvQ43iz">ä¸€çœ¼æ—¥å¸ä»£æŠ½ğŸ‘¿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-obhvq43iz/">
    
    
    
    
    
      
    
    ä¸€çœ¼æ—¥å¸ä»£æŠ½ğŸ‘¿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObF157yEq">å®å®ä½ å¥½æ¼‚äº®ğŸ¥¹ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.nogista_ntv [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obf157yeq/">
    
    
    
    
    
      
    
    å®å®ä½ å¥½æ¼‚äº®ğŸ¥¹<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogista_ntv &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hp5dmnfkbzj31xo1agdqp.jpg">https://tvax3.sinaimg.cn/large/006z6nxLgy1hp5dmnfkbzj31xo1agdqp.jpg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObF16A0IX">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œä¹ƒæœ¨æ‹æºï¼šæ·±æµ·å…‹è‹é² é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obf16a0ix/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨æ‹<!-- raw HTML omitted --><!-- raw HTML omitted -->æºï¼šæ·±æµ·å…‹è‹é² &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5027780187062348%22">https://video.weibo.com/show?fid=1034:5027780187062348&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObFYMrqyu">å•Šå•Šå•Šå•Šå•Šå•Šå¥½å–œæ¬¢å¦¹å¦¹ğŸ¥¹ğŸ«°ğŸ»</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obfymrqyu/">
    
    
    
    
    
      
    
    å•Šå•Šå•Šå•Šå•Šå•Šå¥½å–œæ¬¢å¦¹å¦¹ğŸ¥¹ğŸ«°ğŸ»  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObFzyqbaZ">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ#å±±ä¸‹ç¾æœˆ2ndå†™çœŸé›†##å¥³ä¸»è§’# åœ¨é˜…è¯»ã€Šå¥³ä¸»è§’ã€‹ä¹‹åæ„Ÿè°¢å¤§å®¶å‘å¸ƒäº†å¾ˆå¤šå…³äºå±±ä¸‹ç¾æœˆ2ndå†™çœŸé›†ã€Šå¥³ä¸»è§’ã€‹çš„æ„Ÿæƒ³ï¿½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obfzyqbaz/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%B1%B1%E4%B8%8B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObITOowtQ">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.æ¾æœ¬ç¾é‡Œ X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obitoowtq/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.æ¾æœ¬ç¾é‡Œ X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hp5oaja1asj308c0690sq.jpg%22">https://tvax1.sinaimg.cn/large/006z6nxLgy1hp5oaja1asj308c0690sq.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObITQfp1R">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.27 20:47ã€Œå–µã€ä¹…è¿åœ°è‡ªæ‹äº† [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obitqfp1r/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/ObITTtd3j">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.27 20:48ã€Œè¿™å­©å­çœŸçš„å¥½å¯çˆ±ã€ä»Šå¤©å’Œå¯çˆ±çš„å­©å­ä¸€èµ·å·¥ä½œäº†è™½ç„¶èŠäº†å¾ˆå¤šä½†è¿˜æ˜¯å¯çˆ±åˆ°è®©...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-obitttd3j/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=2315">https://m.weibo.cn/search?containerid=2315</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObDhyf6MK">å«‚å­5æœˆ3è™Ÿè¦å¹«æ¨‚å¤©é‡‘é·²å§‹çƒå¼ï¼Œæ—¥æœŸå’Œå…©å¹´å‰æ™‚é–“ç›¸è¿‘[å“ˆå“ˆ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obdhyf6mk/">
    
    
    
    
    
      
    
    å«‚å­5æœˆ3è™Ÿè¦å¹«æ¨‚å¤©é‡‘é·²å§‹çƒå¼ï¼Œæ—¥æœŸå’Œå…©å¹´å‰æ™‚é–“ç›¸è¿‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/ObGMi6hQJ">åœ¨åˆ¥äººçš„æ¨ç‰¹è£¡ç™¼ç¾ä¹…ä¿ä»Šå¤©å»çœ‹å›‰ï¼ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obgmi6hqj/">
    
    
    
    
    
      
    
    åœ¨åˆ¥äººçš„æ¨ç‰¹è£¡ç™¼ç¾ä¹…ä¿ä»Šå¤©å»çœ‹å›‰ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObDM1l1iz">æ£‹æ‰‹æˆ˜é¹°æƒ³èµ·æœ‰æ®µæ—¶é—´ä¸Šè¯æŒ‡æ•°å’Œä¸­å›½å›´æ£‹ç­‰çº§åˆ†å·®ä¸å¤šï¼Œç°åœ¨è½®åˆ°é¹°é…±èº«é«˜å’Œç¾å…ƒå…‘æ¢æ—¥å…ƒçš„æ¯”æ‹¼äº† [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obdm1l1iz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted -->æƒ³èµ·æœ‰æ®µæ—¶é—´ä¸Šè¯æŒ‡æ•°å’Œä¸­å›½å›´æ£‹ç­‰çº§åˆ†å·®ä¸å¤šï¼Œç°åœ¨è½®åˆ°é¹°é…±èº«é«˜å’Œç¾å…ƒå…‘æ¢æ—¥å…ƒçš„æ¯”æ‹¼äº† <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObE6n55qZ">æˆ‘äºŒè€å©†èƒ½åšæŒåˆ°æˆ‘åˆ°è¡¢å·ç°åœºå°±å·²ç»ä¸é”™äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obe6n55qz/">
    
    
    
    
    
      
    
    æˆ‘äºŒè€å©†èƒ½åšæŒåˆ°æˆ‘åˆ°è¡¢å·ç°åœºå°±å·²ç»ä¸é”™äº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObEL905mk">ä¸Šé‡æ¢¨çº±ï¼šèº«ä¸ºå¦¹å¦¹æˆ‘å¯ä»¥é”è¯„ä¸€ä¸‹ï¼Œæˆ‘å§èµ¢äº†å‰ä¸¤è½®çš„æ—¶å€™æˆ‘ä¹Ÿæ˜¯å¤§åƒä¸€æƒŠã€‚æ®è¯´æ˜¨å¤©æˆ‘å§å‚åŠ äº†ä¸­å›½å›´æ£‹å›½å®¶é˜Ÿçš„è®­ç»ƒã€‚ä»Šå¤©è¿™ç›˜æ£‹è¾œæ¢“è±ªå¯ä»¥è¯´å®Œç¾èº²è¿‡äº†æˆ‘å§çš„å¤§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obel905mk/">
    
    
    
    
    
      
    
    ä¸Šé‡æ¢¨çº±ï¼šèº«ä¸ºå¦¹å¦¹æˆ‘å¯ä»¥é”è¯„ä¸€ä¸‹ï¼Œæˆ‘å§èµ¢äº†å‰ä¸¤è½®çš„æ—¶å€™æˆ‘ä¹Ÿæ˜¯å¤§åƒä¸€æƒŠã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ®è¯´æ˜¨å¤©æˆ‘å§å‚åŠ äº†ä¸­å›½å›´æ£‹å›½å®¶é˜Ÿçš„è®­ç»ƒã€‚ä»Šå¤©è¿™ç›˜æ£‹è¾œæ¢“è±ªå¯ä»¥è¯´å®Œç¾èº²è¿‡äº†æˆ‘å§çš„å¤§é”¤å­ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObGgHxIlr">æ—¥æœ¬ä»£è¡¨å›¢ï¼ˆï¼Ÿï¼‰#å›´æ£‹# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obgghxilr/">
    
    
    
    
    
      
    
    æ—¥æœ¬ä»£è¡¨å›¢ï¼ˆï¼Ÿï¼‰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObGqcpmQB">æ£‹æ‰‹æˆ˜é¹°å“¦å“Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obgqcpmqb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted -->å“¦å“Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/ObHpliBve">äº•å±±è£•å¤ªèµ›åæ„Ÿæƒ³è¿™å‡ å¹´æˆ‘åœ¨ä¸–ç•Œå¤§èµ›ä¸Šä¸€ç›´æ²¡æœ‰å¾ˆå¥½çš„æˆç»©ï¼Œè¿™ä¸€æ¬¡è™½ç„¶åç»­è¿˜æœ‰æ¯”èµ›ï¼Œè‡³å°‘èƒ½æ”¶è·å½“å‰çš„ç»“æœï¼Œæ„Ÿè§‰å¦‚é‡Šé‡è´Ÿã€‚ä¹‹å‰æ¯ä¸€åœºä¸–ç•Œå¤§èµ›ï¼Œæˆ‘éƒ½æ˜¯æ‹¼å°½å…¨åŠ›...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-obhplibve/">
    
    
    
    
    
      
    
    äº•å±±è£•å¤ªèµ›åæ„Ÿæƒ³<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™å‡ å¹´æˆ‘åœ¨ä¸–ç•Œå¤§èµ›ä¸Šä¸€ç›´æ²¡æœ‰å¾ˆå¥½çš„æˆç»©ï¼Œè¿™ä¸€æ¬¡è™½ç„¶åç»­è¿˜æœ‰æ¯”èµ›ï¼Œè‡³å°‘èƒ½æ”¶è·å½“å‰çš„ç»“æœï¼Œæ„Ÿè§‰å¦‚é‡Šé‡è´Ÿã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹‹å‰æ¯ä¸€åœºä¸–ç•Œå¤§èµ›ï¼Œæˆ‘éƒ½æ˜¯æ‹¼å°½å…¨åŠ›é¢å¯¹ï¼Œä½†æ˜¯ä¸€ç›´æ²¡æœ‰å¥½çš„ç»“æœçš„è¯ï¼Œè¯´å®è¯è‡ªå·±ä¹Ÿæƒ³è¿‡ä»Šåè¿˜èƒ½ä¸èƒ½å‚åŠ ä¸–ç•Œå¤§èµ›ï¼Œæ‰€ä»¥è¿™ä¸€æ¬¡å¯¹æˆ‘æ¥è¯´å¯è°“â€œèƒŒæ°´ä¸€æˆ˜â€ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç¬¬ä¸€è½®é¢å¯¹äºšè¿ä¼šä¸ªäººèµ›é‡‘ç‰Œå¾—ä¸»è®¸çš“é‹ä¹æ®µã€‚è¿™ç›˜æ£‹ä¸€ç›´éƒ½éå¸¸éš¾ä¸‹ï¼Œå¯¹æˆ‘æ¥è¯´æˆ˜èƒœå¼ºæ•Œä¹‹åï¼Œä¸ºæˆ‘ä¹‹åçš„å¯¹å±€åšäº†å¾ˆå¥½çš„é“ºå«ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸‹ä¸€è½®ä¼šé—´éš”ä¸€æ®µæ—¶é—´ï¼Œæˆ‘ä¾æ—§ä¼šé›†ä¸­ç²¾åŠ›é¢å¯¹è¿™åœºæ¯”èµ›ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ‘˜è‡ªï¼šæ£‹é“web<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extpar">https://m.weibo.cn/p/index?extpar</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObEFWkpeE">ä¹…ä¿å²ç»ªé‡Œvia.nogista_ntv [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obefwkpee/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogista_ntv <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObEHni7rX">ä¹…ä¿å²ç»ªé‡Œä¹ƒæœ¨æ‹æºï¼šæ·±æµ·å…‹è‹é² é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obehni7rx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨æ‹<!-- raw HTML omitted --><!-- raw HTML omitted -->æºï¼šæ·±æµ·å…‹è‹é² <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObH5G9Y6Q">ä¹…ä¿å²ç»ªé‡Œvia.æ¾æœ¬ç¾é‡Œ X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obh5g9y6q/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.æ¾æœ¬ç¾é‡Œ X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObHVn3jh4">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.27 20:47ã€Œå–µã€ä¹…è¿åœ°è‡ªæ‹äº† [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obhvn3jh4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/ObI1CrE9Y">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.04.27 20:48ã€Œè¿™å­©å­çœŸçš„å¥½å¯çˆ±ã€ä»Šå¤©å’Œå¯çˆ±çš„å­©å­ä¸€èµ·å·¥ä½œäº†è™½ç„¶èŠäº†å¾ˆå¤šä½†è¿˜æ˜¯å¯çˆ±åˆ°è®©æˆ‘çˆ±æ„æ»¡æº¢è€Œå·²æˆ‘å¤ªå–œæ¬¢å¥¹äº†ï¼Œè¿™ä¸ª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obi1cre9y/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/ObEiTC2qq">æŸ¯æ´#ç¬¬äºŒå±Šè¡¢å·çƒ‚æŸ¯æ¯ä¸–ç•Œå›´æ£‹å…¬å¼€èµ›##èµ›äº‹æŠ¥é“# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-obeitc2qq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;extparam=">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;extparam=</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/ObG8tdQPZ">æŸ¯æ´#ç¬¬äºŒå±Šè¡¢å·çƒ‚æŸ¯æ¯ä¸–ç•Œå›´æ£‹å…¬å¼€èµ›##èµ›æœå‘å¸ƒ# æŸ¯æ´ä¹æ®µæ‰§ç™½290æ‰‹è´Ÿå§œä¸œæ¶¦ä¹æ®µã€‚æ­¢æ­¥16å¼ºã€‚ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-obg8tdqpz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;ext">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%AC%AC%E4%BA%8C%E5%B1%8A%E8%A1%A2%E5%B7%9E%E7%83%82%E6%9F%AF%E6%9D%AF%E4%B8%96%E7%95%8C%E5%9B%B4%E6%A3%8B%E5%85%AC%E5%BC%80%E8%B5%9B%23&amp;amp;ext</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/646245714/answer/3480857441">ç‹è¯—ç¿”å›ç­”äº†é—®é¢˜: ä¸ºä»€ä¹ˆé›·å†›è¿™æ ·ä¸€ä¸ªç¾æ¶©å†…å‘çš„ç†å·¥ç”·ï¼Œå´èƒ½å¤Ÿå±¡æ¬¡åˆ›ä¸šæˆåŠŸï¼Œå¼€åˆ›å¥½å‡ ç•ªå¤§äº‹ä¸š?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-646245714-answer-3480857441/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://yufree.cn/cn/2024/04/27/ai-for-science/">ç§‘ç ”ç”¨äººå·¥æ™ºèƒ½</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/yufree-cn-cn-2024-04-27-ai-for-science/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/689615842">ç‹è¯—ç¿”èµåŒäº†æ–‡ç« : äººæ°‘æ—¥æŠ¥æ¨è2024å¹´å¿…è¯»çš„80æœ¬ç»å…¸ä¹¦ç±ï¼Œä½ ä»¬éƒ½è¯»è¿‡å“ªå‡ æœ¬ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-689615842/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694862355">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æ¿€è¿›å¼æŠ¼æ³¨AIæ‰‹æœºçš„å‚å•†ä¸€å¤§å †ï¼Œä¸ºä»€ä¹ˆç™»é¡¶çš„æ˜¯å®ƒå®¶</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694862355/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694871540">é‡å­ä½å‘è¡¨äº†æ–‡ç« : é˜¿é‡Œæ™ºèƒ½ä½“â€œç»„è£…å·¥å‚â€å¼€æºï¼0ç»éªŒæå®šä¸Šä¸‡Agentå¹¶å‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694871540/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694888617">é‡å­ä½å‘è¡¨äº†æ–‡ç« : Llama 3ä½æ¯”ç‰¹é‡åŒ–æ€§èƒ½ä¸‹é™æ˜¾è‘—ï¼å…¨é¢è¯„ä¼°ç»“æœæ¥äº† | æ¸¯å¤§&amp;åŒ—èˆª&amp;ETH</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694888617/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/694888826">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æ¸…åå›¢é˜Ÿå›½äº§â€œSoraâ€ç«äº†ï¼ç”»é¢æ•ˆæœå¯¹æ ‡OpenAIï¼Œé•¿åº¦å¯è¾¾16ç§’ï¼Œè¿˜èƒ½è¯»æ‡‚ç‰©ç†è§„å¾‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-27</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-694888826/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

